These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of arterial thrombosis and platelet function by nafazatrom. Buchanan MR; Blajchman M; Hirsh J Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186 [TBL] [Abstract][Full Text] [Related]
7. Are agents affecting platelet functions clinically useful? Verstraete M Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299 [TBL] [Abstract][Full Text] [Related]
8. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. Goto S; Tamura N; Ishida H J Am Coll Cardiol; 2004 Jul; 44(2):316-23. PubMed ID: 15261925 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy (first of two parts). Weiss HJ N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993 [No Abstract] [Full Text] [Related]
11. Antithrombotic drugs: part II. Gallus AS; Hirsh J Drugs; 1976; 12(2):132-57. PubMed ID: 786606 [TBL] [Abstract][Full Text] [Related]
12. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats. Song Q; Wang S; Zhao W J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682 [TBL] [Abstract][Full Text] [Related]
13. Drug effects on platelet adherence to collagen and damaged vessel walls. Packham MA; Cazenave JP; Kinlough-Rathbone RL; Mustard JF Adv Exp Med Biol; 1978; 109():253-76. PubMed ID: 364949 [TBL] [Abstract][Full Text] [Related]